New NICE Clinical Guidelines: June 2012

Clinical guidelines and technology appraisals published in June by NICE

  • CG141   Acute upper GI bleeding     Clinical guidelines
  • CG142   Autism in adults             Clinical guidelines
  • TA257   Breast cancer  (metastatic hormone-receptor) – lapatinib and trastuzumab (with aromatase inhibitor) Technology appraisals
  • IPG428   Extracorporeal membrane carbon dioxide removal Interventional procedures
  • TA258   Lung cancer (non small cell, EGFR-TK mutation positive) – erlotinib (1st line)   Technology appraisals
  • TA260   Migraine (chronic) – botulinum toxin type A Technology appraisals
  • TA259   Prostate cancer (metastatic, castration resistant) – abiraterone (following cytoxic therapy)  Technology appraisals
  • CG143   Sickle cell acute painful episode    Clinical guidelines
  • CG144   Venous thromboembolic diseases  Clinical guidelines

to view any of the above please click here: NICE guidelines

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s